| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Daniel Broderick Longley | |
| Kelly Marie Redmond | |||
| Patrick Gerard Johnston | |||
| Timothy Richard Wilson | |||
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 5138-5154 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Resistance mechanisms to cancer chemotherapy | |
| P478 | volume | 13 |
| Q33987400 | "Persisters": survival at the cellular level |
| Q89943697 | A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2 |
| Q29614275 | A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations |
| Q28541630 | A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cells |
| Q28487802 | Akt1 enhances CA916798 expression through mTOR pathway |
| Q34686233 | Are cancer stem cells radioresistant? |
| Q42185903 | Arylthioindoles: Promising compounds against cancer cell proliferation |
| Q33920767 | Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. |
| Q43106515 | Cancer: drug-tolerant insurgents |
| Q38374290 | Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer |
| Q41888109 | Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells |
| Q39766082 | Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells |
| Q35832304 | Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria |
| Q39741953 | Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy |
| Q100490624 | Emerging role of tumor cell plasticity in modifying therapeutic response |
| Q38901400 | Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance |
| Q39465605 | Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation |
| Q37525231 | Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor |
| Q34433459 | Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11. |
| Q28477824 | Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment |
| Q34655380 | JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1. |
| Q37958163 | Multidrug resistance associated proteins in multidrug resistance. |
| Q39067495 | PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer |
| Q46242039 | Parameter non-identifiability of the Gyllenberg-Webb ODE model. |
| Q34330361 | Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS |
| Q40989687 | Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion |
| Q42585542 | Return of the malingering mutants |
| Q38055067 | Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? |
| Q39062973 | Significance of OCT1 Expression in Acute Myeloid Leukemia. |
| Q39209758 | Structure-activity relationships of glucosamine-derived glycerolipids: the role of the anomeric linkage, the cationic charge and the glycero moiety on the antitumor activity |
| Q39498444 | TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. |
| Q36624058 | Targeting of cancer‑associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment |
| Q35119820 | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
| Q38965030 | The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53. |
| Q90641451 | The great escape: tumour cell plasticity in resistance to targeted therapy |
| Q37771267 | Therapeutic cancer vaccines in combination with conventional therapy |
| Q34292287 | Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. |
| Q38920037 | Twist1 and Snail link Hedgehog signaling to tumor-initiating cell-like properties and acquired chemoresistance independently of ABC transporters |
| Q39235995 | UVB-irradiated apoptotic cells induce accelerated growth of co-implanted viable tumor cells in immune competent mice. |
| Q42362715 | Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. |
| Q36903223 | α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15 |
Search more.